Cargando…

Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose

Chikungunya virus (CHIKV) is the causative pathogen of chikungunya fever, a mosquito-borne viral disease causing highly debilitating arthralgia that can persist for months and progress to chronic arthritis. Our previous studies have identified the CHIKV live-attenuated vaccine candidate CHIKV-NoLS....

Descripción completa

Detalles Bibliográficos
Autores principales:	Abeyratne, Eranga, Tharmarajah, Kothila, Freitas, Joseph R., Mostafavi, Helen, Mahalingam, Suresh, Zaid, Ali, Zaman, Mehfuz, Taylor, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066069/ https://www.ncbi.nlm.nih.gov/pubmed/32194557 http://dx.doi.org/10.3389/fimmu.2020.00304

Ejemplares similares

Chikungunya: vaccines and therapeutics
por: Tharmarajah, Kothila, et al.
Publicado: (2017)

Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate
por: Abeyratne, Eranga, et al.
Publicado: (2018)

Interleukin-17 contributes to Ross River virus-induced arthritis and myositis
por: Mostafavi, Helen, et al.
Publicado: (2022)

Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease
por: Mostafavi, Helen, et al.
Publicado: (2019)

Altered Spatial and Temporal Gait Parameters in Mice Infected with Ross River Virus
por: Abeyratne, Eranga, et al.
Publicado: (2021)

Modulation of Monocyte-Driven Myositis in Alphavirus Infection Reveals a Role for CX(3)CR1(+) Macrophages in Tissue Repair
por: Zaid, Ali, et al.
Publicado: (2020)

Interleukin-17 Contributes to Chikungunya Virus-Induced Disease
por: Liu, Xiang, et al.
Publicado: (2022)

Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships
por: Zaman, Mehfuz, et al.
Publicado: (2013)

Fighting back against chikungunya
por: Rudd, Penny A, et al.
Publicado: (2015)

Approaches to the treatment of disease induced by chikungunya virus
por: Bettadapura, Jayaram, et al.
Publicado: (2013)

Anti-inflammatory actions of Pentosan polysulfate sodium in a mouse model of influenza virus A/PR8/34-induced pulmonary inflammation
por: Krishnan, Ravi, et al.
Publicado: (2023)

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines
por: Ssemaganda, Aloysious, et al.
Publicado: (2019)

Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design
por: Taylor, Adam, et al.
Publicado: (2017)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism
por: Plante, Kenneth, et al.
Publicado: (2011)

The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan
por: Liu, Xiang, et al.
Publicado: (2022)

Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate
por: Plante, Kenneth S, et al.
Publicado: (2015)

Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated In Vivo and Have Compromised Transmissibility
por: Carrau, Lucía, et al.
Publicado: (2019)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
por: Chan, Yi‐Hao, et al.
Publicado: (2019)

Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection
por: Zaman, Mehfuz, et al.
Publicado: (2021)

Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
por: Schmidt, Christin, et al.
Publicado: (2022)

Mutation of a Conserved Nuclear Export Sequence in Chikungunya Virus Capsid Protein Disrupts Host Cell Nuclear Import
por: Jacobs, Susan C., et al.
Publicado: (2017)

Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus
por: Cao, Liang, et al.
Publicado: (2022)

An attenuated replication-competent chikungunya virus with a fluorescently tagged envelope
por: Jin, Jing, et al.
Publicado: (2018)

Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus
por: Weiss, Christopher M., et al.
Publicado: (2020)

Targeted Delivery of Antifungal Liposomes to Rhizopus delemar
por: Choudhury, Quanita J., et al.
Publicado: (2022)

Imported cases of Chikungunya virus in Iran
por: Pouriayevali, Mohammad Hassan, et al.
Publicado: (2019)

Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice
por: Liu, Xiang, et al.
Publicado: (2021)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
por: Kroon, Jan, et al.
Publicado: (2015)

Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology
por: Jones, Jennifer E., et al.
Publicado: (2017)

FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design
por: Ng, Wern Hann, et al.
Publicado: (2023)

RNA recombination at Chikungunya virus 3'UTR as an evolutionary mechanism that provides adaptability
por: Filomatori, Claudia V., et al.
Publicado: (2019)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
por: García-Arriaza, Juan, et al.
Publicado: (2021)

Seroprevalence of Chikungunya Virus after Its Emergence in Brazil
por: Gérardin, Patrick, et al.
Publicado: (2018)

Comparison of Cytokine Expression Profile in Chikungunya and Dengue Co-Infected and Mono-Infected Patients’ Samples
por: Krishnan, Saravana Murali, et al.
Publicado: (2021)

Targeted delivery of ZNF416 siRNA-loaded liposomes attenuates experimental pulmonary fibrosis
por: Cheng, Demin, et al.
Publicado: (2022)

Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes
por: Liu, Xiaojia, et al.
Publicado: (2023)

Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy
por: Kadry, Mai O.
Publicado: (2019)

Travelers as Sentinels for Chikungunya Fever, Brazil
por: Chaves, Tânia do Socorro Souza, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ob7dqa1c63s7scrhb1mmlbo8ia